Glasgow, United Kingdom

ESTRO 2024

Session

Tuesday
May 07
11:00 - 12:15
Boisdale
Benign disease: A changing paradigm for radiotherapy consideration
Angel Montero, Spain;
Sarah Barrett, Ireland
Is radiotherapy expanding beyond oncology? This session examines the potential for RT in benign disease. First, we will examine the radiobiological basis of low dose RT for non-cancer sites. Afterwards, its clinical applications in rare lymphoproliferative disorders and cardiac arrhythmias will be reviewed and presented by experts in the field. We invite you to join us and discover how radiotherapy can contribute to the treatment of non-cancerous diseases.
4200
Symposium
Interdisciplinary-Radiobiology
11:00 - 11:18
The radiobiological principles of low dose radiotherapy for non-cancer diseases
Nicolas Foray, France
11:36 - 11:54
Low-dose radiotherapy in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
Jennifer Ward, Australia
11:18 - 11:36
Physicist involvement in Stereotactic Arrhythmia Radioablation (STAR): Where does it matter the most and what not to miss?
Oliver Blanck, Germany
11:54 - 12:12
Breath regularisation during stereotactic cardiac radioablation
Irma van Dijk, The Netherlands